SG Americas Securities’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,568
Closed -$56K 3652
2025
Q1
$56K Sell
16,568
-6,476
-28% -$30.3K ﹤0.01% 3215
2024
Q4
$131K Buy
23,044
+10,704
+87% +$69K ﹤0.01% 2527
2024
Q3
$72K Buy
12,340
+1,560
+14% +$11.3K ﹤0.01% 3164
2024
Q2
$85K Buy
+10,780
New +$90.4K ﹤0.01% 2585
2021
Q2
Sell
-126,600
Closed -$596K 3277
2021
Q1
$596K Buy
+126,600
New +$863K ﹤0.01% 1890
2020
Q4
Sell
-9,388
Closed -$100K 3493
2020
Q3
$100K Sell
9,388
-13,728
-59% -$161K ﹤0.01% 2461
2020
Q2
$292K Buy
23,116
+2,333
+11% +$27.1K ﹤0.01% 2532
2020
Q1
$190K Buy
+20,783
New +$239K ﹤0.01% 2541
2019
Q3
Sell
-54,741
Closed -$1.49M 3238
2019
Q2
$1.49M Sell
54,741
-12,638
-19% -$289K 0.01% 1194
2019
Q1
$1.29M Buy
67,379
+6,204
+10% +$80.8K 0.01% 1125
2018
Q4
$575K Buy
61,175
+49,478
+423% +$635K 0.01% 1766
2018
Q3
$221K Sell
11,697
-21,585
-65% -$414K ﹤0.01% 2514
2018
Q2
$650K Buy
+33,282
New +$658K 0.01% 1800
2018
Q1
Sell
-7,117
Closed -$118K 3578
2017
Q4
$118K Sell
7,117
-20,912
-75% -$359K ﹤0.01% 2769
2017
Q3
$577K Buy
+28,029
New +$316K 0.01% 1733
2016
Q4
Sell
-11,195
Closed -$134K 3495
2016
Q3
$134K Buy
+11,195
New +$152K ﹤0.01% 2827

Other funds holding VYGR

SG Americas Securities's VYGR Position: Q2 2025 in Review

SG Americas Securities sold out of Voyager Therapeutics (VYGR) in Q2 2025, closing a stake of 16,568 shares — an estimated $56K sold.

SG Americas Securities first reported a position in VYGR in Q3 2016 and held it in 16 quarters. The position peaked at $1.49M in Q2 2019. 112 funds tracked by Wall St. Rank hold VYGR as of Q2 2025.

  • SG Americas Securities reported no remaining Voyager Therapeutics position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 16,568 Voyager Therapeutics shares in Q2 2025, an estimated $56K.
  • SG Americas Securities first reported a position in Voyager Therapeutics in Q3 2016 and held it in 16 quarters.
  • SG Americas Securities's Voyager Therapeutics position peaked at $1.49M in Q2 2019.
  • 112 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.